{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/anal-fissure/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"464d38ae-bf9a-55c3-a5a8-f26d16c5df49","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 2d8ea118-2be8-4960-869a-7331aa38853e --><h2>Changes</h2><!-- end field 2d8ea118-2be8-4960-869a-7331aa38853e -->","summary":null,"htmlStringContent":"<!-- begin item 683d6415-d6bb-45da-8c1c-8f5b3bf564eb --><!-- begin field d951cea2-7e8f-42db-8ca7-14769363fb7c --><p><strong>January 2017</strong> — minor update. Update to reflect name change of ERIC, The Children's Bowel & Bladder Charity.</p><p><strong>July 2016 </strong>— reviewed. A literature search was conducted in March 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. No major changes to recommendations have been made, but the topic has been restructured.</p><!-- end field d951cea2-7e8f-42db-8ca7-14769363fb7c --><!-- end item 683d6415-d6bb-45da-8c1c-8f5b3bf564eb -->","topic":{"id":"1966ca44-82c6-5654-a1e0-7e73f445ee15","topicId":"28fa6b39-43e9-4444-bb5b-74cb68aa317f","topicName":"Anal fissure","slug":"anal-fissure","lastRevised":"Last revised in January 2017","chapters":[{"id":"5c477a10-68cc-59c7-b721-885d62a44e3f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b8d9e552-3b6d-544d-b5a8-f71baf5f64ef","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"782501f6-e33e-559b-b516-cc016a798a06","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"464d38ae-bf9a-55c3-a5a8-f26d16c5df49","slug":"changes","fullItemName":"Changes"},{"id":"6d8581b7-e7bc-5ace-9067-e7790612065e","slug":"update","fullItemName":"Update"}]},{"id":"16056078-596d-5ebb-8ccc-9390462b0125","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"9864e2c9-5c4d-5bd3-9589-7af84df291ef","slug":"goals","fullItemName":"Goals"},{"id":"ca2ee03c-83a5-5f7a-ae1a-d40584425eca","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a5ab7d4c-07ba-584a-85c9-8993560471fa","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"14cb801e-68ae-5549-8b56-f3677a9043c5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"edf742df-bebc-5b71-b3e6-1777fa29a00a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"1218c321-dc4c-5239-aba3-919e5633ca24","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"dae58dea-1946-5c28-8542-3f71ab339dee","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ae57507c-3884-517d-b28b-b1c7a50c34b5","slug":"definition","fullItemName":"Definition"},{"id":"bbb4426b-3412-53d3-a866-cbcf43067194","slug":"causes","fullItemName":"Causes"},{"id":"81c417d2-aabc-5ba4-8173-a03b78dc8501","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8373fecf-6d3e-5d9e-8a9a-044ee83eb8e9","slug":"prognosis","fullItemName":"Prognosis"},{"id":"d9ea8eda-90ee-570c-b058-9a30e3172b65","slug":"complications","fullItemName":"Complications"}]},{"id":"fedaf0cc-81aa-5cbe-9f52-2aec89f26b4f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ec1128db-c722-548e-a108-2264c18df434","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"419d8e57-b8d9-560b-bc52-564162295c48","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4e5addd6-e78e-58e1-a604-86a9b437edb3","fullItemName":"Management","slug":"management","subChapters":[{"id":"5f1f5405-43b7-5c45-857e-27f84e1df0c6","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"d6022985-bead-5026-a2e0-c6c3649e7f74","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"31fddbe9-fb40-54cb-afa9-8ae0b00dccac","slug":"rectal-glyceryl-trinitrate-04percent-ointment","fullItemName":"Rectal glyceryl trinitrate 0.4% ointment"}]},{"id":"a992f0d8-4130-5649-aa3c-a0e4b5f32564","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"98daeda4-9027-534c-b84c-5c5f7a081238","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6655ced5-a90b-52c5-be48-e2f87b5f23ef","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c1bdadf7-4194-5c80-9368-8ac47ae5f15d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"94472463-588d-5d3f-837a-bb71752d342f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"47703418-f019-5d05-9792-b88a2637fd91","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a4a9ca1f-2c32-5e75-b4fb-2490e84d1eb7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2bfa0c27-50a0-596c-8c66-45dd8cde9177","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"782501f6-e33e-559b-b516-cc016a798a06","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"0b5c2324-2861-569f-9d1e-1bfe897db25f","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 35de268c-f060-4c47-9072-d12c5092c906 --><h3>Previous changes</h3><!-- end field 35de268c-f060-4c47-9072-d12c5092c906 -->","summary":null,"htmlStringContent":"<!-- begin item d3380011-e8b8-4b56-8cda-67b04cd41acf --><!-- begin field c6c9cf32-705d-4f65-855a-7d74e5a6167a --><p><strong>November 2012 </strong>— reviewed. A literature search was conducted in September 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. Minor changes to the structure have been made and a referral section added. Minor changes to the recommendations have been made based on evidence from a Cochrane Systematic review <em>Non-surgical therapy for anal fissure</em>.</p><p><strong>July 2011 </strong>— minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency. Prescriptions have been updated to reflect the revised dosing. Issued in July 2011.</p><p><strong>January 2011 </strong>— topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.</p><p><strong>August 2009 </strong>— minor update. Advice from the National Institute for Health and Care Excellence guideline on when to suspect child maltreatment has been added to this topic. Issued in August 2009.</p><p><strong>January to May 2008 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations.</p><p><strong>October 2005 </strong>— minor update to include a prescription for glyceryl trinitrate 0.4% ointment (now licensed). Issued in November 2005.</p><p><strong>July 2005 </strong>— updated to incorporate the <em>Referral guidelines for suspected cancer </em>published by the National Institute for Health and Clinical Excellence. Issued in July 2005.</p><p><strong>December 2004 </strong>— reviewed. Validated in March 2005 and issued in April 2005.</p><p><strong>September 2001 </strong>— reviewed. Validated in November 2001 and issued in April 2002.</p><p><strong>October 1998 </strong>— written replacing previous guidance on <em>Anal fissure</em>.</p><!-- end field c6c9cf32-705d-4f65-855a-7d74e5a6167a --><!-- end item d3380011-e8b8-4b56-8cda-67b04cd41acf -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}